{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T07:00:31Z","timestamp":1793948431394,"version":"4.8.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T00:00:00Z","timestamp":1662508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T00:00:00Z","timestamp":1662508800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003052","name":"Ministry of Trade, Industry and Energy","doi-asserted-by":"publisher","award":["20013712"],"award-info":[{"award-number":["20013712"]}],"id":[{"id":"10.13039\/501100003052","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s12072-022-10407-7","type":"journal-article","created":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T06:06:09Z","timestamp":1662530769000},"page":"1308-1317","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Long-term cardiovascular outcomes differ across metabolic dysfunction-associated fatty liver disease subtypes among middle-aged population"],"prefix":"10.1007","volume":"16","author":[{"given":"Hokyou","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae Seop","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9658-8050","authenticated-orcid":false,"given":"Seung Up","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeon Chang","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,7]]},"reference":[{"issue":"1","key":"10407_CR1","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73\u201384. https:\/\/doi.org\/10.1002\/hep.28431","journal-title":"Hepatology"},{"issue":"1","key":"10407_CR2","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","volume":"73","author":"M Eslam","year":"2020","unstructured":"Eslam M, Newsome PN, Sarin SK, Anstee QM, Targher G, Romero-Gomez M, et al. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol. 2020;73(1):202\u2013209. https:\/\/doi.org\/10.1016\/j.jhep.2020.03.039","journal-title":"J Hepatol"},{"issue":"7","key":"10407_CR3","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","volume":"158","author":"M Eslam","year":"2020","unstructured":"Eslam M, Sanyal AJ, George J. MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease. Gastroenterology. 2020;158(7):1999-2014.e1991. https:\/\/doi.org\/10.1053\/j.gastro.2019.11.312","journal-title":"Gastroenterology"},{"issue":"10","key":"10407_CR4","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1016\/j.cgh.2020.12.022","volume":"19","author":"H Lee","year":"2021","unstructured":"Lee H, Lee YH, Kim SU, Kim HC. Metabolic dysfunction-associated fatty liver disease and incident cardiovascular disease risk: a nationwide cohort study. Clin Gastroenterol Hepatol. 2021;19(10):2138-2147.e2110. https:\/\/doi.org\/10.1016\/j.cgh.2020.12.022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10407_CR5","doi-asserted-by":"publisher","unstructured":"Lee H, Lee HW, Kim SU, Chang Kim H. Metabolic dysfunction-associated fatty liver disease increases colon cancer risk: a nationwide cohort study. Clin Transl Gastroenterol 2022;13(1):e00435. https:\/\/doi.org\/10.14309\/ctg.0000000000000435","DOI":"10.14309\/ctg.0000000000000435"},{"issue":"11","key":"10407_CR6","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1111\/hepr.13685","volume":"51","author":"T Tsutsumi","year":"2021","unstructured":"Tsutsumi T, Eslam M, Kawaguchi T, Yamamura S, Kawaguchi A, Nakano D, et al. MAFLD better predicts the progression of atherosclerotic cardiovascular risk than NAFLD: generalized estimating equation approach. Hepatol Res. 2021;51(11):1115\u20131128. https:\/\/doi.org\/10.1111\/hepr.13685","journal-title":"Hepatol Res"},{"issue":"9","key":"10407_CR7","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-016640","volume":"7","author":"SC Seong","year":"2017","unstructured":"Seong SC, Kim YY, Park SK, Khang YH, Kim HC, Park JH, et al. Cohort profile: the National Health Insurance Service-National Health Screening Cohort (NHIS-HEALS) in Korea. BMJ Open. 2017;7(9): e016640. https:\/\/doi.org\/10.1136\/bmjopen-2017-016640","journal-title":"BMJ Open"},{"key":"10407_CR8","doi-asserted-by":"publisher","unstructured":"EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J Hepatol 2016;64(6):1388\u20131402. https:\/\/doi.org\/10.1016\/j.jhep.2015.11.004","DOI":"10.1016\/j.jhep.2015.11.004"},{"issue":"9","key":"10407_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0107584","volume":"9","author":"YH Lee","year":"2014","unstructured":"Lee YH, Bang H, Park YM, Bae JC, Lee BW, Kang ES, et al. Non-laboratory-based self-assessment screening score for non-alcoholic fatty liver disease: development, validation and comparison with other scores. PLoS ONE. 2014;9(9): e107584. https:\/\/doi.org\/10.1371\/journal.pone.0107584","journal-title":"PLoS ONE"},{"issue":"2","key":"10407_CR10","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.jhep.2017.11.013","volume":"68","author":"E Vilar-Gomez","year":"2018","unstructured":"Vilar-Gomez E, Chalasani N. Non-invasive assessment of non-alcoholic fatty liver disease: clinical prediction rules and blood-based biomarkers. J Hepatol. 2018;68(2):305\u2013315. https:\/\/doi.org\/10.1016\/j.jhep.2017.11.013","journal-title":"J Hepatol"},{"issue":"22","key":"10407_CR11","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1161\/CIRCULATIONAHA.119.044838","volume":"141","author":"H Lee","year":"2020","unstructured":"Lee H, Yano Y, Cho SMJ, Park JH, Park S, Lloyd-Jones DM, et al. Cardiovascular risk of isolated systolic or diastolic hypertension in young adults. Circulation. 2020;141(22):1778\u20131786. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.119.044838","journal-title":"Circulation"},{"issue":"12","key":"10407_CR12","doi-asserted-by":"publisher","first-page":"6163","DOI":"10.7314\/apjcp.2012.13.12.6163","volume":"13","author":"HJ Seo","year":"2012","unstructured":"Seo HJ, Oh IH, Yoon SJ. A comparison of the cancer incidence rates between the national cancer registry and insurance claims data in Korea. Asian Pac J Cancer Prev. 2012;13(12):6163\u20136168. https:\/\/doi.org\/10.7314\/apjcp.2012.13.12.6163","journal-title":"Asian Pac J Cancer Prev"},{"issue":"6","key":"10407_CR13","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1111\/j.1440-1746.2007.04952.x","volume":"22","author":"JG Fan","year":"2007","unstructured":"Fan JG, Saibara T, Chitturi S, Kim BI, Sung JJ, Chutaputti A, et al. What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific? J Gastroenterol Hepatol. 2007;22(6):794\u2013800. https:\/\/doi.org\/10.1111\/j.1440-1746.2007.04952.x","journal-title":"J Gastroenterol Hepatol"},{"issue":"2","key":"10407_CR14","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1161\/CIRCRESAHA.117.306458","volume":"121","author":"A Bhatnagar","year":"2017","unstructured":"Bhatnagar A. Environmental determinants of cardiovascular disease. Circ Res. 2017;121(2):162\u2013180. https:\/\/doi.org\/10.1161\/CIRCRESAHA.117.306458","journal-title":"Circ Res"},{"issue":"3","key":"10407_CR15","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.jhep.2016.05.013","volume":"65","author":"G Targher","year":"2016","unstructured":"Targher G, Byrne CD, Lonardo A, Zoppini G, Barbui C. Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis. J Hepatol. 2016;65(3):589\u2013600. https:\/\/doi.org\/10.1016\/j.jhep.2016.05.013","journal-title":"J Hepatol"},{"issue":"12","key":"10407_CR16","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1161\/circulationaha.106.658948","volume":"115","author":"CS Fox","year":"2007","unstructured":"Fox CS, Coady S, Sorlie PD, D\u2019Agostino RB Sr, Pencina MJ, Vasan RS, et al. Increasing cardiovascular disease burden due to diabetes mellitus: the Framingham Heart Study. Circulation. 2007;115(12):1544\u20131550. https:\/\/doi.org\/10.1161\/circulationaha.106.658948","journal-title":"Circulation"},{"issue":"3","key":"10407_CR17","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1007\/s00059-016-4414-8","volume":"41","author":"RJ King","year":"2016","unstructured":"King RJ, Grant PJ. Diabetes and cardiovascular disease: pathophysiology of a life-threatening epidemic. Herz. 2016;41(3):184\u2013192. https:\/\/doi.org\/10.1007\/s00059-016-4414-8","journal-title":"Herz"},{"issue":"11","key":"10407_CR18","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1007\/s00535-021-01828-6","volume":"56","author":"M Yoneda","year":"2021","unstructured":"Yoneda M, Yamamoto T, Honda Y, Imajo K, Ogawa Y, Kessoku T, et al. Risk of cardiovascular disease in patients with fatty liver disease as defined from the metabolic dysfunction associated fatty liver disease or nonalcoholic fatty liver disease point of view: a retrospective nationwide claims database study in Japan. J Gastroenterol. 2021;56(11):1022\u20131032. https:\/\/doi.org\/10.1007\/s00535-021-01828-6","journal-title":"J Gastroenterol"},{"issue":"1","key":"10407_CR19","doi-asserted-by":"publisher","first-page":"65","DOI":"10.2337\/cd18-0026","volume":"37","author":"P Golabi","year":"2019","unstructured":"Golabi P, Paik J, Fukui N, Locklear CT, de Avilla L, Younossi ZM. Patients with lean nonalcoholic fatty liver disease are metabolically abnormal and have a higher risk for mortality. Clin Diabetes. 2019;37(1):65\u201372. https:\/\/doi.org\/10.2337\/cd18-0026","journal-title":"Clin Diabetes"},{"issue":"18","key":"10407_CR20","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000006712","volume":"96","author":"H Yoshitaka","year":"2017","unstructured":"Yoshitaka H, Hamaguchi M, Kojima T, Fukuda T, Ohbora A, Fukui M. Nonoverweight nonalcoholic fatty liver disease and incident cardiovascular disease: a post hoc analysis of a cohort study. Medicine (Baltimore). 2017;96(18): e6712. https:\/\/doi.org\/10.1097\/md.0000000000006712","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"10407_CR21","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1080\/17474124.2018.1460202","volume":"12","author":"FB Lu","year":"2018","unstructured":"Lu FB, Hu ED, Xu LM, Chen L, Wu JL, Li H, et al. The relationship between obesity and the severity of non-alcoholic fatty liver disease: systematic review and meta-analysis. Expert Rev Gastroenterol Hepatol. 2018;12(5):491\u2013502. https:\/\/doi.org\/10.1080\/17474124.2018.1460202","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"6","key":"10407_CR22","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1016\/j.cgh.2021.07.016","volume":"20","author":"OT Ahmed","year":"2022","unstructured":"Ahmed OT, Gidener T, Mara KC, Larson JJ, Therneau TM, Allen AM. Natural history of nonalcoholic fatty liver disease with normal body mass index: a population-based study. Clin Gastroenterol Hepatol. 2022;20(6):1374-1381.e1376. https:\/\/doi.org\/10.1016\/j.cgh.2021.07.016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10407_CR23","doi-asserted-by":"publisher","unstructured":"Han E, Lee YH, Kim YD, Kim BK, Park JY, Kim DY, et al. Nonalcoholic fatty liver disease and sarcopenia are independently associated with cardiovascular risk. Am J Gastroenterol 2020;115(4):584\u2013595. https:\/\/doi.org\/10.14309\/ajg.0000000000000572","DOI":"10.14309\/ajg.0000000000000572"},{"issue":"10","key":"10407_CR24","doi-asserted-by":"publisher","first-page":"2960","DOI":"10.1111\/jgh.15589","volume":"36","author":"N Tamaki","year":"2021","unstructured":"Tamaki N, Kurosaki M, Takahashi Y, Itakura Y, Inada K, Kirino S, et al. Liver fibrosis and fatty liver as independent risk factors for cardiovascular disease. J Gastroenterol Hepatol. 2021;36(10):2960\u20132966. https:\/\/doi.org\/10.1111\/jgh.15589","journal-title":"J Gastroenterol Hepatol"},{"key":"10407_CR25","doi-asserted-by":"publisher","DOI":"10.5009\/gnl210084","author":"Y Kim","year":"2021","unstructured":"Kim Y, Han E, Lee JS, Lee HW, Kim BK, Kim MK, et al. Cardiovascular risk is elevated in lean subjects with nonalcoholic fatty liver disease. Gut Liver. 2021. https:\/\/doi.org\/10.5009\/gnl210084","journal-title":"Gut Liver"},{"issue":"1","key":"10407_CR26","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12933-017-0536-4","volume":"16","author":"E Han","year":"2017","unstructured":"Han E, Lee YH, Lee BW, Kang ES, Lee IK, Cha BS. Anatomic fat depots and cardiovascular risk: a focus on the leg fat using nationwide surveys (KNHANES 2008\u20132011). Cardiovasc Diabetol. 2017;16(1):54. https:\/\/doi.org\/10.1186\/s12933-017-0536-4","journal-title":"Cardiovasc Diabetol"},{"issue":"2","key":"10407_CR27","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1093\/annonc\/mdn565","volume":"20","author":"J Polesel","year":"2009","unstructured":"Polesel J, Zucchetto A, Montella M, Dal Maso L, Crispo A, La Vecchia C, et al. The impact of obesity and diabetes mellitus on the risk of hepatocellular carcinoma. Ann Oncol. 2009;20(2):353\u2013357","journal-title":"Ann Oncol"},{"key":"10407_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2021.06.042","author":"W Sohn","year":"2021","unstructured":"Sohn W, Kwon HJ, Chang Y, Ryu S, Cho YK. Liver fibrosis in Asians with metabolic dysfunction-associated fatty liver disease. Clin Gastroenterol Hepatol. 2021. https:\/\/doi.org\/10.1016\/j.cgh.2021.06.042","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"10407_CR29","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.jhep.2021.06.013","volume":"75","author":"X Chen","year":"2021","unstructured":"Chen X, Chen S, Pang J, Tang Y, Ling W. Are the different MAFLD subtypes based on the inclusion criteria correlated with all-cause mortality? J Hepatol. 2021;75(4):987\u2013989. https:\/\/doi.org\/10.1016\/j.jhep.2021.06.013","journal-title":"J Hepatol"},{"key":"10407_CR30","doi-asserted-by":"publisher","unstructured":"Lee JI, Lee HW, Lee KS, Lee HS, Park JY. Effects of statin use on the development and progression of nonalcoholic fatty liver disease: a nationwide nested case\u2013control study. Am J Gastroenterol 2021;116(1):116\u2013124. https:\/\/doi.org\/10.14309\/ajg.0000000000000845","DOI":"10.14309\/ajg.0000000000000845"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-022-10407-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-022-10407-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-022-10407-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,26]],"date-time":"2022-11-26T20:39:50Z","timestamp":1669495190000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12072-022-10407-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,7]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["10407"],"URL":"https:\/\/doi.org\/10.1007\/s12072-022-10407-7","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,7]]},"assertion":[{"value":"31 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008. The study protocol was approved by the Institutional Review Board of Yonsei University Health System, Seoul, Korea (#Y-2019\u20130081) with a waiver of informed consent because this was a retrospective study of de-identified, routinely collected data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights statement"}}]}}